USES: May temporarily relieve: • fearfullness • restlessness • fear of death and dying** **Claims based on traditional homeopathic practice, not accepted medical evidence. Not FDA evaluated.
INDICATIONS: May temporarily relieve fearfulness, restlessness, and fear of death and dying.** **Claims based on traditional homeopathic practice, not accepted medical evidence. Not FDA evaluated.
HUIZHOU JINSHENG MEDICAL TECHNOLOGY CO., LTD
FDA
OTC
Straighten the cleaning solution Pour it into the cleaning position for cleaning Usage: This product is designed for gentle cleaning of the face, mouth, nose, eyes,ears, and wounds. It can also be used with a nebulizer to help relieve discomfort in the nose and mouth.
Saline Solution is intended for use in OTC ear,nose,and throat devices intended specifically to administer medicinal substances to treat ear,nose,and throat disorders.These instruments include the powder blower,dropper,ear wick,manual nebulizer pump,and nasal inhaler. If using with an OTC ear,nose,or throat device,the follow the directions provided with the device and only use as directed.
HUIZHOU JINSHENG MEDICAL TECHNOLOGY CO., LTD
FDA
OTC
Usage: This product is designed for gentle cleaning of the face, mouth, nose, eyes, ears, and wounds. It can also be used with a nebulizer to help relieve discomfort in the nose and mouth.
HF ACQUISITION CO LLC, DBA HEALTHFIRST
FDA
Rx Only
Sodium Chloride Injection, USP is a sterile, nonpyrogenic solution for fluid and electrolyte replenishment in single dose containers for intravenous administration. It contains no antimicrobial agents. The pH ranges from 4.5 to 7.0. Composition, osmolarity, and ionic concentration are shown below: 0.9% Sodium Chloride Injection, USP contains 9 g/L Sodium Chloride, USP (NaCl) with an osmolarity of 308 mOsmol/L (calc). It contains 154 mEq/L sodium and 154 mEq/L chloride. The FLEBOFLEX and FLEBOFLEX LUER plastic containers are fabricated from latex-free polyolefins or polypropylene plastic materials. The solution contact materials do not contain PVC, DEHP, or other plasticizers. The amount of water that can permeate from inside the container into the overwrap is insufficient to affect the solution significantly. The suitability of the container materials has been established through biological evaluations, which have shown the containers pass Class VI U.S. Pharmacopeia (USP) testing for plastic containers. These tests confirm the biological safety of the container systems.
HF ACQUISITION CO LLC, DBA HEALTHFIRST
FDA
Rx Only
Sodium Chloride Injection, USP solutions are sterile and nonpyrogenic. They are parenteral solutions containing various concentrations of sodium chloride in water for injection intended for intravenous administration. For 0.45% Sodium Chloride Injection, USP, each 100 mL contains 450 mg sodium chloride in water for injection. Electrolytes per 1000 mL: sodium 77 mEq; chloride 77 mEq. The osmolarity is 154 mOsmol/L (calc.). For 0.9% Sodium Chloride Injection, USP, each 100 mL contains 900 mg sodium chloride in water for injection. Electrolytes per 1000 mL: sodium 154 mEq; chloride 154 mEq. The osmolarity is 308 mOsmol/L (calc.). The pH for both concentrations in the 100 mL and smaller containers is 6.0; for the 250 mL and larger containers, the pH is 5.6. The pH range is 4.5 to 7.0 for all containers. The solutions contain no bacteriostat, antimicrobial agent or added buffer and each is intended only as a single-dose injection. When smaller doses are required the unused portion should be discarded. The solutions are parenteral fluid and electrolyte replenishers. Sodium Chloride, USP is chemically designated NaCl, a white crystalline powder freely soluble in water. Water for Injection, USP is chemically designated H2O. The flexible plastic container is fabricated from a specially formulated polyvinylchloride. Water can permeate from inside the container into the overwrap but not in amounts sufficient to affect the solution significantly. Solutions in contact with the plastic container may leach out certain chemical components from the plastic in very small amounts; however, biological testing was supportive of the safety of the plastic container materials. Exposure to temperatures above 25°C (77°F) during transport and storage will lead to minor losses in moisture content. Higher temperatures lead to greater losses. It is unlikely that these minor losses will lead to clinically significant changes within the expiration period.
HF ACQUISITION CO LLC, DBA HEALTHFIRST
FDA
Rx Only
Sodium Chloride Injection, USP solutions are sterile and nonpyrogenic. They are parenteral solutions containing various concentrations of sodium chloride in water for injection intended for intravenous administration. For 0.45% Sodium Chloride Injection, USP, each 100 mL contains 450 mg sodium chloride in water for injection. Electrolytes per 1000 mL: sodium 77 mEq; chloride 77 mEq. The osmolarity is 154 mOsmol/L (calc.). For 0.9% Sodium Chloride Injection, USP, each 100 mL contains 900 mg sodium chloride in water for injection. Electrolytes per 1000 mL: sodium 154 mEq; chloride 154 mEq. The osmolarity is 308 mOsmol/L (calc.). The pH for both concentrations in the 100 mL and smaller containers is 6.0; for the 250 mL and larger containers, the pH is 5.6. The pH range is 4.5 to 7.0 for all containers. The solutions contain no bacteriostat, antimicrobial agent or added buffer and each is intended only as a single-dose injection. When smaller doses are required the unused portion should be discarded. The solutions are parenteral fluid and electrolyte replenishers. Sodium Chloride, USP is chemically designated NaCl, a white crystalline powder freely soluble in water. Water for Injection, USP is chemically designated H2O. The flexible plastic container is fabricated from a specially formulated polyvinylchloride. Water can permeate from inside the container into the overwrap but not in amounts sufficient to affect the solution significantly. Solutions in contact with the plastic container may leach out certain chemical components from the plastic in very small amounts; however, biological testing was supportive of the safety of the plastic container materials. Exposure to temperatures above 25°C (77°F) during transport and storage will lead to minor losses in moisture content. Higher temperatures lead to greater losses. It is unlikely that these minor losses will lead to clinically significant changes within the expiration period.
HF ACQUISITION CO LLC, DBA HEALTHFIRST
FDA
Rx Only
Sodium Chloride Injection, USP solutions are sterile and nonpyrogenic. They are parenteral solutions containing various concentrations of sodium chloride in water for injection intended for intravenous administration. For 0.45% Sodium Chloride Injection, USP, each 100 mL contains 450 mg sodium chloride in water for injection. Electrolytes per 1000 mL: sodium 77 mEq; chloride 77 mEq. The osmolarity is 154 mOsmol/L (calc.). For 0.9% Sodium Chloride Injection, USP, each 100 mL contains 900 mg sodium chloride in water for injection. Electrolytes per 1000 mL: sodium 154 mEq; chloride 154 mEq. The osmolarity is 308 mOsmol/L (calc.). The pH for both concentrations in the 100 mL and smaller containers is 6.0; for the 250 mL and larger containers, the pH is 5.6. The pH range is 4.5 to 7.0 for all containers. The solutions contain no bacteriostat, antimicrobial agent or added buffer and each is intended only as a single-dose injection. When smaller doses are required the unused portion should be discarded. The solutions are parenteral fluid and electrolyte replenishers. Sodium Chloride, USP is chemically designated NaCl, a white crystalline powder freely soluble in water. Water for Injection, USP is chemically designated H2O. The flexible plastic container is fabricated from a specially formulated polyvinylchloride. Water can permeate from inside the container into the overwrap but not in amounts sufficient to affect the solution significantly. Solutions in contact with the plastic container may leach out certain chemical components from the plastic in very small amounts; however, biological testing was supportive of the safety of the plastic container materials. Exposure to temperatures above 25°C (77°F) during transport and storage will lead to minor losses in moisture content. Higher temperatures lead to greater losses. It is unlikely that these minor losses will lead to clinically significant changes within the expiration period.
HF ACQUISITION CO LLC, DBA HEALTHFIRST
FDA
Rx Only
This preparation is designed solely for parenteral use only after addition of drugs that require dilution or must be dissolved in an aqueous vehicle prior to injection. 0.9% Sodium Chloride Injection, USP is a sterile, nonpyrogenic, isotonic solution of sodium chloride and water for injection. Each mL contains sodium chloride 9 mg. It contains no bacteriostat, antimicrobial agent or added buffer and is supplied only in single-dose containers to dilute or dissolve drugs for injection. 0.308 mOsmol/mL (calc.). 0.9% Sodium Chloride Injection, USP contains no preservatives. The solution may contain hydrochloric acid and/or sodium hydroxide for pH adjustment. pH 5.3 (4.5 to 7.0). Sodium Chloride, USP is chemically designated NaCl, a white crystalline compound freely soluble in water. The glass container is a Type I borosilicate glass and meets the requirements of the powdered glass test according to the USP standards. The semi-rigid vial is fabricated from a specially formulated polyolefin. It is a copolymer of ethylene and propylene. The safety of the plastic has been confirmed by tests in animals according to USP biological standards for plastic containers. The container requires no vapor barrier to maintain the proper drug concentration.
HF ACQUISITION CO LLC, DBA HEALTHFIRST
FDA
Rx Only
0.9% Sodium Chloride Injection, USP solution is sterile and nonpyrogenic. It is a parenteral solution containing sodium chloride in water for injection intended for intravenous administration. For 0.9% Sodium Chloride Injection, USP, each 100 mL contains 900 mg sodium chloride in water for injection. Electrolytes per 1,000 mL: sodium 154 mEq; chloride 154 mEq. The osmolarity is 308 mOsmol/L (calc.). The pH in the 100 mL and smaller containers is 6.0; for the 250 mL and larger containers, the pH is 5.6. The pH range is 4.5 to 7.0 for all containers. The solution contains no bacteriostat, antimicrobial agent or added buffer and is intended only as a single-dose injection. When smaller doses are required the unused portion should be discarded. The solution is a parenteral fluid and electrolyte replenisher. Sodium Chloride, USP is chemically designated NaCl, a white crystalline powder freely soluble in water. Water for injection, USP is chemically designated H2O. The flexible container is fabricated from a specially formulated non-plasticized, film containing polypropylene and thermoplastic elastomers (freeflex® bag). The amount of water that can permeate from the container into the overwrap is insufficient to affect the solution significantly. Solutions in contact with the flexible container can leach out certain of the container's chemical components in very small amounts within the expiration period. The suitability of the container material has been confirmed by tests in animals according to USP biological tests for plastic containers.
12 CELL SALTS COMPLEXCALCAREA FLUORICA CALCAREA PHOSPHORICA CALCAREA SULPHURICA FERRUM PHOSPHORICUM KALI MURIATICUM KALI PHOSPHORICUM KALI SULPHURICUM MAGNESIA PHOSPHORICA NATRUM MURIATICUM NATRUM PHOSPHORICUM NATRUM SULPHURICUM SILICEA
INDICATIONS: For weight management and inflammation support. This homeopathic product has not been evaluated by the Food and Drug Administration for safety or efficacy. FDA is not aware of scientific evidence to support homeopathy as effective.
3% Sodium Chloride Injection, USP is a sterile, nonpyrogenic, hypertonic solution for fluid and electrolyte replenishment in single dose containers for intravenous administration. The pH may have been adjusted with hydrochloric acid. It contains no antimicrobial agents. Composition, ionic concentration, osmolarity, and pH are shown in Table 1 . Table 1. *Normal physiological osmolarity range is approximately 280 to 310 mOsmol/L. Size (mL) Composition (g/L) Ionic Concentration (mEq/L) *Osmolarity (mOsmol/L) (calc) pH Sodium Chloride, USP (NaCl) Sodium Chloride 3% Sodium Chloride Injection, USP 500 30 513 513 1,027 5.0 (4.5 to 7.0) The flexible container is fabricated from a specially formulated non-plasticized, film containing polypropylene and thermoplastic elastomers (free flex ® bag). The amount of water that can permeate from the container into the overwrap is insufficient to affect the solution significantly. Solutions in contact with the flexible container can leach out certain of the container's chemical components in very small amounts within the expiration period. The suitability of the container material has been confirmed by tests in animals according to USP biological tests for plastic containers.
4 Kids Cold and Cough DaytimeONION CALCIUM SULFIDE SODIUM CHLORIDE PHOSPHORUS PULSATILLA VULGARIS SULFUR AND GOLDENSEAL
Uses* ■ Helps temporarily relieve symptoms of common cold in children at night, including: ■ cough ■ runny nose ■ post nasal drip ■ sneezing ■ sore throat ■ nasal or chest congestion ■ occasional sleeplessness
Uses ■ Helps temporarily relieve symptoms of common cold in children at night, including: ■ cough ■ runny nose ■ post nasal drip ■ sneezing ■ sore throat ■ nasal or chest congestion ■ occasional sleeplessness
4 Kids Cold and Mucus NighttimeEUPHRASIA STRICTASILICON DIOXIDE RUMEX CRISPUS ROOT ANEMONE PULSATILLA GOLDENSEAL SODIUM CHLORIDE PHOSPHORUS ONION BRYONIA ALBA ROOT MATRICARIA CHAMOMILLA ARABICA COFFEE BEAN CALCIUM SULFIDE AND SULFUR
Uses Temporarily relieves the symptoms of the common cold in children especially at night including accumulation of mucus in chest, throat and nose, cough with mucus, runny nose, sneezing, nasal congestion and occasional sleeplessness.
4 KIDS COLD N COUGH GRAPE FLAVORONION CALCIUM SULFIDE GOLDENSEAL SODIUM CHLORIDE PHOSPHORUS ANEMONE PULSATILLA AND SULFUR
Uses ■Temporarily relieves symptoms of common cold in children, including: ■ accumulation of mucus in chest, throat or nose ■ cough with expectoration of thick, discolored mucus ■ runny nose ■ sneezing ■ nasal or chest congestion
911 Adrenal Burnout and FatigueACETICUM AC ADRENALINUM ADRENOCORTICOTROPHIN 30X AESCULUS HIPPOCASTANUM FLOS ALFALFA ALPHA LIPOIC AC AMBRA ARG NIT AVENA SATIVA BRYONIA CARBONEUM OXYGENISATUM CARPINUS BETULUS FLOS DNA FUMARICUM ACIDUM GELSEMIUM SEMPERVIRENS HEPAR SULPHURIS CALCAREUM HYPOTHALAMUS KALI PHOSPHORICUM LACTICUM ACIDUM LECITHIN NATRUM MURIATICUM OXALICUM ACIDUM PHOSPHORICUM ACIDUM PITUITARUM POSTERIUM SARCOLACTICUM ACIDUM SELENIUM METALLICUM SEPIA SILICEA SUCCINICUM ACIDUM AND THYROIDINUM.
Uses † for temporary relief of: physical fatigue mental and emotional fatigue nervous exhaustion sluggish mind poor concentration weariness confusion apathy irritability indifference body aches lack of focus eyes sensitive to light digestive symptoms caused by stress light-headed upon standing up † Claims based on traditional Homeopathic practice, not accepted medical evidence, not FDA evaluated.
By Active Ingredients
Drugs sharing any active ingredients
Anpituapar Adrenocorticotrophin, Agnus Castus, Baryta Carbonica, Calcarea Carbonica, Iodium, Natrum Muriaticum, Phosphoricum Acidum, Sepia, Thyroidinum (Suis), Lac Caninum CORTICOTROPIN CORTICOTROPIN CHASTE TREE CHASTE TREE BARIUM CARBONATE BARIUM CATION OYSTER SHELL CALCIUM CARBONATE, CRUDE OYSTER SHELL CALCIUM CARBONATE, CRUDE IODINE IODINE SODIUM CHLORIDE CHLORIDE ION PHOSPHORIC ACID PHOSPHORIC ACID SEPIA OFFICINALIS JUICE SEPIA OFFICINALIS JUICE SUS SCROFA THYROID SUS SCROFA THYROID CANIS LUPUS FAMILIARIS MILK CANIS LUPUS FAMILIARIS MILK WATER ALCOHOL
INDICATIONS: May temporarily relieve weakness, weariness, thirst, PMS, and bone pain.** **Claims based on traditional homeopathic practice, not accepted medical evidence. Not FDA evaluated.
HOMEOPATHIC INDICATIONS: For the temporary relief of the symptoms of nausea and vomiting associated with pain, pregnancy, vertigo, and headache.** **These statements are based upon homeopathic principles. They have not been reviewed by the Food and Drug Administration.
INDICATIONS: For temporary relief of symptoms related to bronchial cough including irritating cough, difficult breathing, congestion, and respiratory inflammation.
INDICATIONS: For temporary relief of gastrointestinal dyspepsia (indigestion) with flatulence, bloating and intolerance of certain foods. Remedy #1 supports detoxification and cellular repair.
INDICATIONS For temporary relief of allergic rhinitis with runny nose, nasal mucus with yellow-green discharge, pain & swelling of sinus cavities, and nasal drip.
INDICATIONS: For temporary relief of pain in the abdomen extending around to the back, pain in the thighs and loins on urinating and frequent urination.
INDICATIONS AND USAGE For temporary relief of weakness, weariness, thirst, PMS, and bone pain. These statements are based upon traditional homeopathic practice. They have not been reviewed by the Food and Drug Administration.
INDICATIONS: For temporary relief of heartburn and distention, burning on urination, flatulence, apathy; and may improve digestion associated with fungal conditions.** **These statements are based upon traditional homeopathic practice. They have not been reviewed by the Food and Drug Administration.
HOMEOPATHIC INDICATIONS: For temporary relief of symptoms related to heavy metal toxicity including cough, poor concentration, nausea, vomiting, diarrhea, stomach pain, headache, sweating, and a metallic taste in the mouth.** **These statements are based upon traditional homeopathic principles. They have not been reviewed by the Food and Drug Administration.
Envirostat Berberis Vulgaris, Chelidonium Majus, Lappa Major, Phytolacca Decandra, Calcarea Fluorica, Carbo Animalis, Nux Vomica BERBERIS VULGARIS ROOT BARK BERBERIS VULGARIS ROOT BARK CHELIDONIUM MAJUS CHELIDONIUM MAJUS ARCTIUM LAPPA ROOT ARCTIUM LAPPA ROOT PHYTOLACCA AMERICANA ROOT PHYTOLACCA AMERICANA ROOT CALCIUM FLUORIDE FLUORIDE ION CARBO ANIMALIS CARBO ANIMALIS STRYCHNOS NUX-VOMICA SEED STRYCHNOS NUX-VOMICA SEED PHOSPHORUS PHOSPHORUS SEPIA OFFICINALIS JUICE SEPIA OFFICINALIS JUICE SULFUR SULFUR THUJA OCCIDENTALIS LEAF THUJA OCCIDENTALIS LEAF WATER ALCOHOL
INDICATIONS AND USAGE For temporary relief of head congestion and general exhaustion as a consequence of exposure to smog, dust, or industrial agents. **These statements are based upon traditional homeopathic practice. They have not been reviewed by the Food and Drug Administration.
ASP Echinacea (Angustifolia), Hydrastis canadensis, Tabebuia impetiginosa, Glandula suprarenalis suis, Thymus(suis), Thyroidinum (suis), Arsenicum album, ECHINACEA ANGUSTIFOLIA ECHINACEA ANGUSTIFOLIA GOLDENSEAL GOLDENSEAL TABEBUIA IMPETIGINOSA BARK TABEBUIA IMPETIGINOSA BARK SUS SCROFA ADRENAL GLAND SUS SCROFA ADRENAL GLAND SUS SCROFA THYMUS SUS SCROFA THYMUS SUS SCROFA THYROID SUS SCROFA THYROID ARSENIC TRIOXIDE ARSENIC CATION (3+) BRYONIA ALBA ROOT BRYONIA ALBA ROOT ANAMIRTA COCCULUS SEED ANAMIRTA COCCULUS SEED COLCHICUM AUTUMNALE BULB COLCHICUM AUTUMNALE BULB LEDUM PALUSTRE TWIG LEDUM PALUSTRE TWIG MERCURIC CYANIDE MERCURIC CYANIDE SODIUM SULFATE SODIUM SULFATE ANHYDROUS PULSATILLA VULGARIS PULSATILLA VULGARIS SEPIA OFFICINALIS JUICE SEPIA OFFICINALIS JUICE SILICON DIOXIDE SILICON DIOXIDE ASPERGILLUS FLAVUS ASPERGILLUS FLAVUS WATER ALCOHOL
INDICATIONS: For temporary relief of symptoms of cough with expectoration and dyspepsia, ill effects of melons, water and dried fruits, thick yellow ropy mucous secretions.
INDICATIONS: May temporarily relieve symptoms associated with coffee, tea, and chocolate allergies.** **Claims based on traditional homeopathic practice, not accepted medical evidence. Not FDA evaluated.
INDICATIONS: For temporary relief of allergic rhinitis with runny nose, nasal mucus with yellow-green discharge, pain & swelling of sinus cavities, and nasal drip.